Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Revenues
Total revenues	$ 592,183	$ 439,758	$ 1,640,615	$ 1,220,850
Cost and expenses
Research and development	173,412	96,931	448,917	274,677
Selling, general and administrative	308,546	214,154	885,962	606,397
Total cost and expenses	689,759	479,096	1,927,741	1,378,404
Loss from operations	(97,576)	(39,338)	(287,126)	(157,554)
Interest expense	(1,045)	(3,142)	(3,078)	(9,393)
Interest and other income, net	11,284	11,618	35,441	32,342
Loss before income taxes	(87,337)	(30,862)	(254,763)	(134,605)
Income tax expense	(207)	(730)	(655)	(2,050)
Net loss	(87,544)	(31,592)	(255,418)	(136,655)
Unrealized (loss) gain on available-for-sale securities, net of tax	100	593	157	2,320
Comprehensive loss	$ (87,444)	$ (30,999)	$ (255,261)	$ (134,335)
Net loss per share (Note 12):
Basic (in dollars per share)	$ (0.64)	$ (0.26)	$ (1.88)	$ (1.12)
Diluted (in dollars per share)	$ (0.64)	$ (0.26)	$ (1.88)	$ (1.12)
Weighted-average number of shares used in computing basic and diluted net loss per share:
Basic (in shares)	137,187	123,775	136,181	122,486
Diluted (in shares)	137,187	123,775	136,181	122,486
Product
Revenues
Total revenues	$ 590,197	$ 436,127	$ 1,634,660	$ 1,212,163
Cost and expenses
Cost of revenues	207,253	167,657	591,397	496,340
Licensing and other
Revenues
Total revenues	1,986	3,631	5,955	8,687
Cost and expenses
Cost of revenues	$ 548	$ 354	$ 1,465	$ 990